Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation

Transplantation Proceedings

Volumn 37, Issue 10, 2005, Pages 4373-4379

  Orr, D W ^a   Portmann, B C ^a   Knisely, A S ^a   Stoll, S ^a   Rela, M ^a   Muiesan, P ^a   Bowles, M J ^a   Heaton, N D ^a   O'Grady, J G ^a   Heneghan, M A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BASILIXIMAB; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIOPSY; CHEMICAL ANALYSIS; CLINICAL ARTICLE; DEATH; EVALUATION; FEMALE; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MALE; OPERATION DURATION; PATIENT; PRIORITY JOURNAL;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, MONOCLONAL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 29544437779     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.10.022     Document Type: Article

References (37)

1. F. Conti, B. Dousset, D. Archambeau Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients Transplantation 60 1995 1104
2. R. Hirose, J.P. Roberts, D. Quan Experience with daclizumab in liver transplantation Transplantation 69 2000 307
3. H. Andreu, A. Rimola, M. Bruguera Acute cellular rejection in liver transplant recipients under cyclosporin immunosuppression predictive factors of response to antirejection therapy Transplantation 74 2002 1936
4. H.R. Rosen, C.R. Shackleton, L. Higa Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation Am J Gastroenterol 92 1997 1453
5. U.P. Neumann, T. Berg, M. Bahra Long-term outcome of liver transplants for chronic hepatitis C a 10- year follow-up Transplantation 77 2004 226
6. K.A. Smith Interleukin-2 inception, impact and implications Science 240 1988 1169
7. T. Nikaido, A. Shimizu, N. Ishida Molecular cloning of cDNA encoding human interleukin-2 receptor Nature 311 1984 631
8. M. Koch, G. Niemeyer, I. Patel Pharmacokinetics, pharmacodynamics, and immunodynamics of daclizumab in a two-dose regimen in liver transplantation Transplantation 73 2002 1640
9. T.G. Heffron, T. Pillen, G.A. Smallwood Pediatric liver transplantation with daclizumab induction therapy Transplantation 75 2003 2040
10. A. Strassburg, E.D. Pfister, A. Arning Basiliximab reduces acute liver allograft rejection in pediatric patients Transplant Proc 34 2002 2374
11. M. Asensio, C. Margarit, R. Chavez Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids Transplant Proc 34 2002 1970
12. W. Petz, M. Spada, A. Bertani Experience with the use of basiliximab in liver transplantation use in pediatric and adult recipients in combination with cyclosporin or tacrolimus Transplant Proc 34 2002 1966
13. M.M. Aw, R.M. Taylor, A. Verma Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transplant recipients a preliminary experience Transplantation 75 2003 796
14. M.N. Chariat, M. Erren, M. Chariat Basiliximab in the therapy of acute rejection after organ transplantation Transplant Proc 33 2001 2380
15. R. Pfitzmann, J. Klupp, J.M. Langrehr Mycophenolate mofetil for immunosuppression after liver transplantation a follow-up study of 191 patients Transplantation 76 2003 130
16. J.M. Langrehr, A. Schneller, O. Guckelberger Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation Transplant Proc 30 1998 1439
17. B. Nashan, H.J. Schlitt, R. Schwinzer Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients Transplantation 61 1996 546
18. D. Adu, P. Cockwell, N.J. Ives Interleukin-2 receptor monoclonal antibodies in renal transplantation meta-analysis of randomised trials BMJ 326 2003 789
19. C.R. Gregory, X. Huang, R.E. Pratt Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement Transplantation 59 1995 655
20. P. Hayry Pathophysiology of chronic rejection Transplant Proc 28 6 suppl 1 1996 7
21. J. Kobashigawa, L. Miller, D. Renlund A randomised active-controlled trial of mycophenolate mofetil in heart transplant recipients Transplantation 66 1998 507
22. European mycophenolate mofetil Cooperative Study Group Mycophenolate mofetil in renal transplantation 3-year results from the placebo-controlled trial Transplantation 68 1999 391
23. D.E. Eckhoff, B. McGuire, M. Sellers The safety and efficacy of a two-dose daclizumab (Zenepax) induction therapy in liver transplant recipients Transplantation 69 2000 1867
24. L. Yan, W. Wang, B. Li Single-dose daclizumab induction therapy in patients with liver transplantation World J Gastroenterol 9 2003 1881
25. European Mycophenolate Mofetil Cooperative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection Lancet 345 1995 1321
26. T.H. Mathew A blinded, long-term, randomised multicenter study of mycophenolate mofetil in cadaveric renal transplantation Transplantation 65 1998 1450
27. Z. Ben-Ari, H. Weiss-Schilovitz, J. Sulkes Serum cholestasis markers as predictors of early outcome after liver transplantation Clin Transplant 18 2004 130
28. A.D. Pinna, C. Ricordi, D. Weppler Treatment of recurrent hepatitis C after liver transplantation with IL-2r Ab Transplant Proc 33 2001 1087
29. P. Neuhaus, P. Clavien, D. Kittur Improved treatment response with basiliximab immunoprophylaxis after liver transplantation results from a double-blind randomised placebo-controlled trial Liver Transplant 8 2002 132
30. K.P. Platz, A.R. Mueller, T. Berg Searching for the optimal management of hepatitis C patients after liver transplantation Transplant Int 11 suppl 1 1998 S209
31. D.R. Nelson, C. Soldevila-Pico, A. Reed Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation Liver Transplant 7 2001 1064
32. M. Berenguer, F.X. Lopez-Labrador, T.L. Wright Hepatitis C and liver transplantation J Hepatology 35 2001 666
33. V. Ratziu, D. Samuel, M. Sebagh Long-term follow-up after liver transplantation for autoimmune hepatitis evidence of recurrence of primary disease J Hepatol 30 1999 131
34. S. Narumi, K. Hakamada, M. Saski Liver transplantation for autoimmune hepatitis rejection and recurrence Transplant Proc 31 1999 1955
35. D.J. Reich, I. Fiel, J.V. Guarrea Liver transplantation for autoimmune hepatitis Hepatology 32 2000 693
36. N. Kerkar, N. Hadzic, E.T. Davies De-novo autoimmune hepatitis after liver transplantation Lancet 351 1998 409
37. M.A. Heneghan, B.C. Portmann, S.M. Norris Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults Hepatology 34 2001 464